Monday, November 16, 2026 1:07 PM ET
2 hours ago
Feds arrest top healthcare company official, alleging illegal drug importation2 hours ago
Measles is surging in the U.S. — and outbreaks can cost millions5 days ago
FDA warns of vision loss risk linked to GLP-1 drugs like Wegovy, Zepbound5 days ago
Eli Lilly's obesity pill eases sleep apnea in late-stage trial6 days ago
Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?7 days ago
Could CRISPR cure rare diseases before birth? Scientists are getting closer5 days ago
Moderna hikes 2026 sales growth outlook, smashes quarterly estimates5 days ago
Jim Cramer says the AI trade is not going away as Nasdaq enters correction11 days ago
CVS Health plans to split itself up. Here's why a breakup could make sense now11 days ago
Jim Cramer says this bank stock is a buy after its post-election pullback12 days ago
CVS falls on plans to split off drugstore business in major breakup11 days ago
Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook12 days ago
Pfizer hikes 2026 outlook as new products grow, taps company veteran as new CFO12 days ago
Midterm elections could jolt stocks as Democrats look poised to sweep Congress12 days ago
A biotech's high-stakes cancer bet just paid off and its shares doubled13 days ago
Jim Cramer says lower oil prices are giving stocks a boost. Can it last?13 days ago
Stocks started the week higher but ended in despair. Our take on the big reversal13 days ago
Cramer's week ahead: Expect more volatility as tech earnings, midterms loom16 days ago
Gen Z is ditching bars for run clubs — and finding more than friends along the way17 days ago
A pharma major is touting an MS drug to ease patent-cliff fears17 days ago
West Pharma: More than a GLP-1 play. The case for further upside17 days ago
Cramer sees opportunity amid tech turmoil and predicts a holiday win for FedEx18 days ago
Merck tops estimates, hikes profit outlook on strength of injectable Keytruda18 days ago
Eli Lilly blows past estimates, hikes sales outlook on resilient GLP-1 demand18 days ago
GLP-1 coverage is shrinking for 2027. Here are weight-loss options for workers18 days ago
Measles resurgence exposes deeper weaknesses in U.S. public health, experts say19 days ago
Cramer: I asked tech insiders what to buy. They surprisingly said this drug stock20 days ago
Amgen says drug combo slashes risk of death by 58% in patients with lung cancer21 days ago
Doctors call Moderna, Merck's cancer vaccine data a major advancement23 days ago
Moderna shares plunge after cancer vaccine data leaks — despite positive results24 days ago
New bipartisan bill aims to speed up clinical trials for rare disease treatments25 days ago